Sentence examples for is detectable in blood from inspiring English sources

(The PGA Tour also tested a urine sample from Singh, which found no banned substances. IGF-1 is detectable in blood, which is not tested under the tour's antidoping policy).

Myoglobin is the earliest biochemical marker of myocardial cell damage, and it is detectable in blood within 1 to 2 h of myocardial damage [19].

We employed GLuc as a sample biomarker for this proof of principle because GLuc is 1000 times brighter than other luciferases, is more sensitive than secretable alkaline phosphatase, and is detectable in blood and urine in vivo [27], [28].

The extent of intestinal damage is detectable in blood drawn on presentation at the ER.

The entire extracellular domain is released into the extracellular space and is detectable in blood, urine, and cerebrospinal fluid [ 40].

HEV RNA is detectable in blood from as early as two weeks before and for two to four weeks after the onset of symptoms.

This is because the active compounds in marijuana are absorbed slowly into the body, and may be detectable in blood samples long after impairment has passed.

"In the past, we have tried to look in the blood for differences between healthy people and cancer patients," says Carbone. "We've had some success, but it's not as specific as we would like". So researchers are now looking for markers specific to tumor cells, and then determining whether those markers are detectable in blood.

The Italian team and a separate group led by oncologist Luis Diaz of Johns Hopkins University in Baltimore, Maryland, have now independently found that the KRAS mutations are detectable in blood samples from patients whose tumors became drug resistant, a technique Bardelli calls a "liquid biopsy".

In contrast, plasma cells and MSP1-specific antibody-secreting cells (ASC) were detectable in blood only within a narrow time period, approximately 10 days following infection.

The finding that Ma2 is expressed in primary SI-NETs and metastases [13] prompted us to screen whether Ma2 autoantibodies are detectable in blood of NET patients to establish potential novel biomarkers and to evaluate their clinical implications in tumor diagnosis and prognosis.